Bioactivation and covalent binding of halothane in vitro

Studies with [3H]- and [14C]halothane

A Jay Gandolfi, R. D. White, I. G. Sipes, L. R. Pohl

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

To determine if the hydrogen atom of halothane (CF3CHBrCl) is retained on the reactive intermediates that covalently bind to microsomal lipids and protein [3H]halothane and [14C]halothane were incubated with rat hepatic microsomes and a NADPH generating system. Both [3H]- and [14C]halothane were bioactivated and bound to a greater degree when incubations were performed in a N2 atmosphere rather than an O2 atmosphere. In fact, covalent binding of 3H-equivalents did not occur under an O2 atmosphere. Binding of [3H]- and [14C] halothane equivalents was significantly enhanced when hepatic microsomes from phenobarbital- or Aroclor 1254-treated rats were used in the incubations. Omission of NADPH or incubation with CO was inhibitory to the binding of both [3H]- and [14C]halothane. The apparent kinetic constants for binding of halothane equivalents, Km and Vmax indicate a significantly higher Km but lower Vmax for the formation and/or binding of 3H-binding equivalents. The results indicate that halothane is primarily bioactivated under conditions that promote its reductive metabolism and that this reductive metabolism does not involve cleavage of the carbon-hydrogen bond of halothane. Differences in binding under N2 and O2 as well as between [3H]- and [14C]halothane suggest that multiple reactive intermediates may form during the biotransformation of halothane.

Original languageEnglish (US)
Pages (from-to)721-725
Number of pages5
JournalJournal of Pharmacology and Experimental Therapeutics
Volume214
Issue number3
StatePublished - 1980

Fingerprint

Halothane
Atmosphere
Microsomes
NADP
Hydrogen
In Vitro Techniques
Chlorodiphenyl (54% Chlorine)
Liver
Carbon Monoxide
Phenobarbital
Biotransformation
Carbon
Lipids

ASJC Scopus subject areas

  • Pharmacology

Cite this

Bioactivation and covalent binding of halothane in vitro : Studies with [3H]- and [14C]halothane. / Gandolfi, A Jay; White, R. D.; Sipes, I. G.; Pohl, L. R.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 214, No. 3, 1980, p. 721-725.

Research output: Contribution to journalArticle

@article{8babcfc69d264971a5ee3e8de0ab28e6,
title = "Bioactivation and covalent binding of halothane in vitro: Studies with [3H]- and [14C]halothane",
abstract = "To determine if the hydrogen atom of halothane (CF3CHBrCl) is retained on the reactive intermediates that covalently bind to microsomal lipids and protein [3H]halothane and [14C]halothane were incubated with rat hepatic microsomes and a NADPH generating system. Both [3H]- and [14C]halothane were bioactivated and bound to a greater degree when incubations were performed in a N2 atmosphere rather than an O2 atmosphere. In fact, covalent binding of 3H-equivalents did not occur under an O2 atmosphere. Binding of [3H]- and [14C] halothane equivalents was significantly enhanced when hepatic microsomes from phenobarbital- or Aroclor 1254-treated rats were used in the incubations. Omission of NADPH or incubation with CO was inhibitory to the binding of both [3H]- and [14C]halothane. The apparent kinetic constants for binding of halothane equivalents, Km and Vmax indicate a significantly higher Km but lower Vmax for the formation and/or binding of 3H-binding equivalents. The results indicate that halothane is primarily bioactivated under conditions that promote its reductive metabolism and that this reductive metabolism does not involve cleavage of the carbon-hydrogen bond of halothane. Differences in binding under N2 and O2 as well as between [3H]- and [14C]halothane suggest that multiple reactive intermediates may form during the biotransformation of halothane.",
author = "Gandolfi, {A Jay} and White, {R. D.} and Sipes, {I. G.} and Pohl, {L. R.}",
year = "1980",
language = "English (US)",
volume = "214",
pages = "721--725",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Bioactivation and covalent binding of halothane in vitro

T2 - Studies with [3H]- and [14C]halothane

AU - Gandolfi, A Jay

AU - White, R. D.

AU - Sipes, I. G.

AU - Pohl, L. R.

PY - 1980

Y1 - 1980

N2 - To determine if the hydrogen atom of halothane (CF3CHBrCl) is retained on the reactive intermediates that covalently bind to microsomal lipids and protein [3H]halothane and [14C]halothane were incubated with rat hepatic microsomes and a NADPH generating system. Both [3H]- and [14C]halothane were bioactivated and bound to a greater degree when incubations were performed in a N2 atmosphere rather than an O2 atmosphere. In fact, covalent binding of 3H-equivalents did not occur under an O2 atmosphere. Binding of [3H]- and [14C] halothane equivalents was significantly enhanced when hepatic microsomes from phenobarbital- or Aroclor 1254-treated rats were used in the incubations. Omission of NADPH or incubation with CO was inhibitory to the binding of both [3H]- and [14C]halothane. The apparent kinetic constants for binding of halothane equivalents, Km and Vmax indicate a significantly higher Km but lower Vmax for the formation and/or binding of 3H-binding equivalents. The results indicate that halothane is primarily bioactivated under conditions that promote its reductive metabolism and that this reductive metabolism does not involve cleavage of the carbon-hydrogen bond of halothane. Differences in binding under N2 and O2 as well as between [3H]- and [14C]halothane suggest that multiple reactive intermediates may form during the biotransformation of halothane.

AB - To determine if the hydrogen atom of halothane (CF3CHBrCl) is retained on the reactive intermediates that covalently bind to microsomal lipids and protein [3H]halothane and [14C]halothane were incubated with rat hepatic microsomes and a NADPH generating system. Both [3H]- and [14C]halothane were bioactivated and bound to a greater degree when incubations were performed in a N2 atmosphere rather than an O2 atmosphere. In fact, covalent binding of 3H-equivalents did not occur under an O2 atmosphere. Binding of [3H]- and [14C] halothane equivalents was significantly enhanced when hepatic microsomes from phenobarbital- or Aroclor 1254-treated rats were used in the incubations. Omission of NADPH or incubation with CO was inhibitory to the binding of both [3H]- and [14C]halothane. The apparent kinetic constants for binding of halothane equivalents, Km and Vmax indicate a significantly higher Km but lower Vmax for the formation and/or binding of 3H-binding equivalents. The results indicate that halothane is primarily bioactivated under conditions that promote its reductive metabolism and that this reductive metabolism does not involve cleavage of the carbon-hydrogen bond of halothane. Differences in binding under N2 and O2 as well as between [3H]- and [14C]halothane suggest that multiple reactive intermediates may form during the biotransformation of halothane.

UR - http://www.scopus.com/inward/record.url?scp=0018849787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018849787&partnerID=8YFLogxK

M3 - Article

VL - 214

SP - 721

EP - 725

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -